{"id":113506,"date":"2023-11-09T17:21:27","date_gmt":"2023-11-09T11:51:27","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=113506"},"modified":"2023-11-09T17:22:45","modified_gmt":"2023-11-09T11:52:45","slug":"pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/","title":{"rendered":"Pharma stock jumps up to 8% after it announces acquisition of business units worth \u20b9 366 Cr from Biocon"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2884286443\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of this pharmaceutical company jumped up to 8 percent to hit an all-time high price of Rs 971.30 per share after the company announced the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics Ltd.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3402282732\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/ERIS\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Eris Lifesciences Ltd<\/a><\/strong> is a small-cap company with a market capitalization of Rs 12,209 crores. On Thursday, The company shares closed at Rs 913.30 a share, an increase of 1.75 percent from the previous close price of Rs 897.6 a share.\u00a0<\/p><p>According to the company\u2019s filing, Eris Lifesciences Ltd the company announced the acquisition of Nephrology and Dermatology Branded Formulations business units worth Rs 366 crores of Biocon Biologics Ltd, with the entire field workforce of this business, consisting of over 120 personnel.&nbsp;<\/p><p>In addition to the stated above, After the acquisition, Eris Lifesciences Ltd will become the 2nd largest player in Psoriasis with an 11 percent market share and Dermatology is all set to become Eris\u2019 third largest therapy soon, after Diabetes and Cardiovascular, With dominant market position in three of the top-5 chronic therapies.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-75959469\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Examining the business&#8217;s financials, the company\u2019s revenue increased 9.7 percent from Rs. 460.51 crores in Q2FY23 to Rs 505.3 crores in Q2FY24. Further, During the same period, Net Profit increased by 2.45 percent from Rs 119.38 crores to Rs 122.31 crores.&nbsp;<\/p><p>The company reported excellent return ratios in the recent financial year with a return on equity (ROE) of 18.25 percent and a return on capital employed (ROCE) of 17.31 percent.&nbsp;<\/p><p>Eris Lifesciences Ltd recent shareholding pattern, the company&#8217;s promoters own 54.91 percent, retail shareholders own a 17.37 percent stake and foreign institutional investors own a 13.2 percent stake in the company.&nbsp;<\/p><p>Eris Lifesciences Ltd stock gave a return of 43.46 percent in six months and 28.33 percent in a year.\u00a0ERIS Lifesciences Ltd is engaged in the business of manufacturing and marketing pharmaceutical products.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by:- Abhishek Singh<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-2671320139\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of this pharmaceutical company jumped up to 8 percent to hit an all-time high price of Rs 971.30 per share after the company announced the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics Ltd.&nbsp; Eris Lifesciences Ltd is a small-cap company with a market capitalization of Rs 12,209 crores. [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":82826,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[14229,14228,14227,948,936],"class_list":["post-113506","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-eris-lifesciences-acquisition","tag-eris-lifesciences-latest-news","tag-eris-lifesciences-share-price","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps up to 8% after it announces acquisition of business units worth \u20b9 366 Cr from Biocon - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of this pharmaceutical company jumped up to 8 percent to hit an all-time high price of Rs 971.30 per share after the company announced the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics Ltd.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps up to 8% after it announces acquisition of business units worth \u20b9 366 Cr from Biocon\" \/>\n<meta property=\"og:description\" content=\"The shares of this pharmaceutical company jumped up to 8 percent to hit an all-time high price of Rs 971.30 per share after the company announced the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics Ltd.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-09T11:51:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-09T11:52:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/\",\"name\":\"Pharma stock jumps up to 8% after it announces acquisition of business units worth \u20b9 366 Cr from Biocon - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\",\"datePublished\":\"2023-11-09T11:51:27+00:00\",\"dateModified\":\"2023-11-09T11:52:45+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of this pharmaceutical company jumped up to 8 percent to hit an all-time high price of Rs 971.30 per share after the company announced the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics Ltd.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps up to 8% after it announces acquisition of business units worth \u20b9 366 Cr from Biocon\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps up to 8% after it announces acquisition of business units worth \u20b9 366 Cr from Biocon - Trade Brains Features","description":"The shares of this pharmaceutical company jumped up to 8 percent to hit an all-time high price of Rs 971.30 per share after the company announced the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics Ltd.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps up to 8% after it announces acquisition of business units worth \u20b9 366 Cr from Biocon","og_description":"The shares of this pharmaceutical company jumped up to 8 percent to hit an all-time high price of Rs 971.30 per share after the company announced the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics Ltd.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-11-09T11:51:27+00:00","article_modified_time":"2023-11-09T11:52:45+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/","name":"Pharma stock jumps up to 8% after it announces acquisition of business units worth \u20b9 366 Cr from Biocon - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","datePublished":"2023-11-09T11:51:27+00:00","dateModified":"2023-11-09T11:52:45+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of this pharmaceutical company jumped up to 8 percent to hit an all-time high price of Rs 971.30 per share after the company announced the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics Ltd.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-up-to-8-after-it-announces-acquisition-of-business-units-worth-366-cr-from-biocon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps up to 8% after it announces acquisition of business units worth \u20b9 366 Cr from Biocon"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/113506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=113506"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/113506\/revisions"}],"predecessor-version":[{"id":113508,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/113506\/revisions\/113508"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/82826"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=113506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=113506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=113506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}